Supraflex Cruz - Improving patient outcomes: from simple to complex patients

Sponsored by SMT
Coronary Interventions
Multivessel disease
Stable CAD
Stents, scaffolds and DCB
Tools and Technique
Room 251

Anchorperson: Patrick Serruys

Spokesperson: Faisal Sharif

Discussants: Ignacio J Amat-Santos, Gianluca Campo, Helge Möllmann, Valeria Paradies, Ashok Seth, Joanna Wykrzykowska

Speakers: Simone Biscaglia, Pruthvi Chenniganahosahalli Revaiah, Upendra Kaul, Arpad Lux, Pieter Smits, Azfar G Zaman

Watch this session if you want

  • To learn that the treatment spectrum of Supraflex Cruz DES encompasses both simple and complex coronary artery disease (CAD)
  • To learn the safety and efficiency of Supraflex Cruz across all patient strata (real world clinical practice; randomised control trials; elderly; high bleeding risk, diabetes)
  • To learn the optimal contemporary approach in PCI, encompassing (a) patient selection, (b) physiology to decide on revascularisation, (c) intravascular imaging to optimise PCI and (d) optimal medical therapy, within the ongoing trials addressing 3-vessel disease with and without diabetes mellitus
Session objectives

Faisal Sharif

Performance of Supraflex Cruz in large registries: (1) - UK Registry

Azfar G Zaman

Performance of Supraflex Cruz in large registries: (2) - Dutch Registry

Arpad Lux

Supraflex Cruz use in elderly patient population

Simone Biscaglia

Supraflex Cruz use in patients with high bleeding risk (HBR)

Pieter Smits

Supraflex Cruz use in diabetic patients with multivessel coronary artery disease (CAD)

Upendra Kaul

Contemporary best practice with Supraflex Cruz in patients with three vessel coronary artery disease (CAD)

Pruthvi Chenniganahosahalli Revaiah

Session evaluation and key learnings

Patrick Serruys

Discussion and audience interaction